From Bortezomib to other Inhibitors of the Proteasome and Beyond

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|22|4025-4038

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.22, 2013-07, pp. : 4025-4038

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 517-536

Bentham Science Publishers

Access to resources Recommend Favorite

A review of the proteasome inhibitor bortezomib in multiple myeloma

By Richardson Paul G  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1321-1331

Informa Healthcare

Access to resources Recommend Favorite

Proteasome Inhibition in Transplantation-Focusing on the Experience with Bortezomib

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3299-3304

Bentham Science Publishers

Access to resources Recommend Favorite

The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib

By  

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1483-1499

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Structure, Function, and Lessons Learned from Beta-Lactone Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 23, 2011-12 ,pp. : 2850-2878

Bentham Science Publishers

Access to resources Recommend Favorite